ICICI Prudential Healthcare Fund-Growth
The fund is rated 4 stars. The strongest areas were investment selection within each asset type and investment selection within each industry, while balance between returns and downside risk provided some support. Higher annual fee of 2.07% and above-average fund size of Rs 6,802.61 crore were minor drawbacks.
This fund has a good track record with Asset Selection/Timing, a good track record with Stock Selection/Timing. It is important to note, however, that this fund has a 6802.61 AUM and a 2.07 expense ratio. Considering all these factors, we have rated this fund as 4.0 star.
आमचा स्कोअर दीर्घकालीन कामगिरी, जोखीम आणि सातत्य यांचे वजन करतो — फक्त मागील परतावे नाही.
परतावा
21 Sep 2026 पर्यंत
जोखीम गुणोत्तरे
31 Aug 2026 पर्यंत
पोर्टफोलिओ
31 Aug 2026 पर्यंत
मार्केट-कॅप विभागणी
क्षेत्रनिहाय वाटप
होल्डिंग्स (36)
| होल्डिंग | फंडाचा % | मूल्य | शेअर्स |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.31% | ₹861.02 Cr | 43,38,091 |
| Dr. Reddy's Laboratories Ltd. | 8.26% | ₹578.12 Cr | 50,08,009 |
| Cipla Ltd. | 5.76% | ₹402.74 Cr | 28,57,946 |
| Mankind Pharma Ltd. | 5.21% | ₹364.6 Cr | 15,07,093 |
| Alkem Laboratories Ltd. | 4.87% | ₹340.98 Cr | 6,39,791 |
| Divi's Laboratories Ltd. | 4.83% | ₹337.57 Cr | 3,56,579 |
| Others | 4.78% | ₹334.29 Cr | — |
| Biocon Ltd. | 4.68% | ₹327.26 Cr | 79,43,167 |
| Medplus Health Services Ltd. | 4.15% | ₹290.26 Cr | 43,17,751 |
| Cohance Lifesciences Ltd. | 4.08% | ₹285.73 Cr | 62,66,692 |
फंड तपशील
Long term wealth creation. An Equity Scheme that predominantly invests in Equity and Equity related securities of companies in Healthcare Sector.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Exit load of 1% if redeemed within 15 days.